The Pediatric Dermatologist's View of Pediatric Vitiligo

Authors:
  • MWMark Weingarten
    Mark Weingarten
  • MSMichelle Schwartz
    Michelle Schwartz
  • CHCandrice Heath
    Candrice Heath
  • NSNanette B. Silverberg
    Nanette B. Silverberg

Abstract
Background: No guidelines exist for pediatric vitiligo. Objective: To identify practice patterns of pediatric dermatologists treating vitiligo. Methods: A PeDRA survey was completed online by 56 pediatric dermatologists. Results: Practitioners reported feeling most comfortable treating 13- to 17-year-olds and least comfortable treating infants. Quality of life was assessed by interview in 89.3%. Topical calcineurin inhibitors (TCIs), topical corticosteroids (TCSs), narrowband UVB, coverup makeup, topical JAK inhibitors (tJAKis), and 308-nm laser were the leading vitiligo therapeutics chosen. 94.5% of practitioners reported experiencing frustration due to difficulties procuring therapies. Conclusion: Pediatric vitiligo has notable effects on quality of life. Some therapeutic options exist which are preferred by pediatric dermatologists. There is a need for more data on therapeutics in infants and young children, J Drugs Dermatol. 2024;23(2): doi:10.36849/JDD.7572ePediatric Vitiligo